Bio-Techne to Acquire Asuragen

MINNEAPOLIS and AUSTIN, Texas, March 3, 2021  /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, today announced it has reached an agreement to acquire Asuragen, [...]

March 3rd, 2021|News|